Loading...

IMMX IMMIX BIOPHARMA INC Investments/Divestments 8-K Filing

MMX

MMX

IMMIX BIOPHARMA INC

(IMMX)

2024 8-K

Show Summary

Show Summary

Equity Offerings

Investment Grant

Change of Accounting Firm

Equity Incentive Plan Amend...

Underwriting Agreement

Suspension of Stock Offering

Private Placement

Annual Meeting Results

ATM Sales Agreement

Entry into Material Definit...

Investment Agreement

External Links:

Immix Biopharma's subsidiary, Nexcella, Inc., has been awarded an $8 million grant from the California Institute for Regenerative Medicine.

AI Assistant

IMMIX BIOPHARMA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.